Cost-effectiveness explorer

Move a new treatment around the cost-effectiveness plane, and see what happens when its carbon footprint is priced in.

A new treatment costs more (or less) than current care and produces more (or fewer) QALYs. Is it worth funding? Change the inputs below.

Things to try

  1. Set extra QALYs to a negative value with negative cost. Which quadrant are you in, and what does the ICER mean there?
  2. Keep the treatment just cost-effective, then raise the carbon value. When does the decision flip?
  3. Why do economists often prefer the net monetary benefit to the ICER?